Steven Boyd
Director, Vaxart.
Companies
- TENAX THERAPEUTICS, INC.Board member Aug 21, 2020 to May 19, 20221
- Avalo Therapeutics, Inc.Board member May 23, 2017 to Mar 14, 20222
- KIORA PHARMACEUTICALS INCBoard member May 16, 2018 to Jul 29, 20213
- AYTU BIOPHARMA, INCBoard member Apr 22, 2019 to May 10, 20214
- Tetraphase Pharmaceuticals (United States)Board member Jan 31, 2020 to Jul 30, 20205
- VaxartBoard member Nov 7, 2019 to Jun 30, 20206
- Del Frisco's Restaurant GroupBoard member Dec 4, 2018 to Dec 4, 20187
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avalo Therapeutics, Inc. AVTX47,762,442 shares8$553.1M at $11.58Mar 7, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 7, 2022Bought 325,000 shares at $0.66 of Avalo Therapeutics, Inc.8
- Mar 4, 2022Bought 135,000 shares at $0.70 of Avalo Therapeutics, Inc.8
- Mar 3, 2022Bought 50,000 shares at $0.71 of Avalo Therapeutics, Inc.8
- Feb 22, 2022Bought 83,000 shares at $0.77 of Avalo Therapeutics, Inc.9
- Feb 18, 2022Bought 55,000 shares at $0.82 of Avalo Therapeutics, Inc.9
- Feb 17, 2022Bought 150,000 shares at $0.82 of Avalo Therapeutics, Inc.9
- Jan 14, 2022Bought 85,000 shares at $0.93 of Avalo Therapeutics, Inc.10
- Jan 13, 2022Bought 312,700 shares at $1.00 of Avalo Therapeutics, Inc.10
- Jan 12, 2022Bought 57,300 shares at $1.04 of Avalo Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAYTU BIOPHARMA, INC, Board member
- 5
- 6SEC EDGARVaxart, Board member
- 7
- 8
- 9SEC EDGARForm 4 filed Feb 22, 2022
- 10SEC EDGARForm 4 filed Jan 14, 2022